Lifetime lease takes LI complex to 100% occupancy.

Lifetime Brands, Inc., a leading designer, developer and marketer of a broad range of nationally branded consumer products used in the home and one of Long Island's Top100 companies, has signed a lease to take additional space in the Business and Research Center at Garden City.

The deal, which brings occupancy in the building at 1000 Stewart Ave., to 100%, was announced by Joseph A. Farkas, president of Metropolitan Realty Associates LLC, the owner of the distinctive mixed-use building. The complete lease up of the property was accomplished in just 13 months from its acquisition.

Lifetime Brands soon to be the largest tenant in the building, agreed to lease an additional 18,495 s/f of office space. The company, now in Westbury, previously agreed to lease 114, 474 s/f of space in the former Bristol Myers-Squibb Pharma complex for its executive offices, research and product development center, warehouse and showrooms. Lifetime Brands, which is expected to move into the building in December, will occupy a total 133,000 s/f in the 155,000 s/f building. Other soon-to-be-tenants include Angion Biomedica and Home Medical Equipment.

Garden City, NY-based Metropolitan Realty Associates owns the architecturally distinctive complex, which contain 186,500 s/f on 7.55 acres and is comprised of two buildings, 1000 Stewart Ave., which is 161,500 s/f and is 100% leased, and 500 Endo Blvd., which is 25,000 s/f and is being converted to professional/medical office space. Space is still available in 500 Endo Boulevard.

Douglas Omstrom and Thomas DiMicelli of Corporate National Realty LLC of Woodbury, NY, are the exclusive leasing agents for the two buildings. Lifetime was represented in the transaction by Richard Karson, Martin Lomazow and Phil Heilpern of CB Richard Ellis.

The former pharmaceutical manufacturing complex, designed in the 1960s by the world famous architect, Paul Rudolph, was acquired by Metropolitan Realty Associates in August 20005. The building originally served as the world headquarters, laboratory and manufacturing plant of Endo Laboratories. After Endo was sold in 1969 to E.I. DuPont de Nemours and Co., the building was used as a pharmaceutical plant by a succession of companies that included DuPont Pharmaceuticals and Bristol-Myers Squibb. The building never previously had been available for lease to a variety of tenants.